Ciliary Neurotrophic Factor - A Promising New Therapy for Macular Telangiectasia Type 2.
Saved in:
| Title: | Ciliary Neurotrophic Factor - A Promising New Therapy for Macular Telangiectasia Type 2. |
|---|---|
| Authors: | Duncan JL; Department of Ophthalmology, University of California, San Francisco, San Francisco. |
| Source: | NEJM evidence [NEJM Evid] 2025 Aug; Vol. 4 (8), pp. EVIDe2500127. Date of Electronic Publication: 2025 Jul 22. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2766-5526 (Electronic) Linking ISSN: 27665526 NLM ISO Abbreviation: NEJM Evid Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
